Drugs & Therapy Perspectives | 2001(17) articles
- Aminolevulinic acid: bright future for a new photodynamic therapy for actinic keratosis?
- Individualised therapy for migraine possible as the triptan family expands
- HMG-CoA reductase inhibitors: useful in stroke prevention?
- Preventive measures help patients with diabetes see into the future
- First reports of adverse drug reactions (ADRs) in recent weeks
- New in the marketplace